PRGO:NYE-Perrigo Company PLC (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 28.16

Change

+0.14 (+0.50)%

Market Cap

N/A

Volume

0.79M

Analyst Target

USD 57.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

+0.77 (+0.39%)

USD 83.17B
HLN Haleon plc

-0.10 (-0.94%)

USD 47.33B
TAK Takeda Pharmaceutical Co Ltd A..

-0.03 (-0.20%)

USD 46.60B
RDY Dr. Reddy’s Laboratories Ltd..

-0.74 (-0.93%)

USD 13.37B
CTLT Catalent Inc

-0.03 (-0.05%)

USD 10.83B
ELAN Elanco Animal Health

+0.36 (+2.52%)

USD 7.15B
BHC Bausch Health Companies Inc

+0.84 (+11.70%)

USD 2.95B
AMRX Amneal Pharmaceuticals, Inc. C..

-0.12 (-1.36%)

USD 2.70B
CPHI China Pharma Holdings Inc

N/A

USD 3.94M
YCBD cbdMD Inc

-0.05 (-9.23%)

USD 1.92M

ETFs Containing PRGO

FLWR:SW 15.27 % 0.00 %

N/A

N/A
HLIT:CA Global X Lithium Producer.. 9.49 % 0.00 %

-0.27 (-0.80%)

CAD 0.02B
ION Proshares S&P Global Core.. 3.98 % 0.00 %

-0.18 (-0.80%)

USD 2.24M
SETM:LSE HANetf ICAV - Sprott Ener.. 3.48 % 0.00 %

-0.04 (-0.80%)

USD 4.23M
SDIU:LSE Global X SuperDividend UC.. 1.20 % 0.00 %

-0.03 (-0.80%)

USD 0.24M
WSRD:CA Wealthsimple Developed Ma.. 1.10 % 0.00 %

-0.21 (-0.80%)

CAD 0.69B
GNRX 0.00 % 0.55 %

N/A

N/A
PILL Direxion Daily Pharmaceut.. 0.00 % 0.98 %

+0.11 (+-0.80%)

N/A
XPH SPDR® S&P Pharmaceutical.. 0.00 % 0.35 %

+0.28 (+-0.80%)

N/A
ISRL:LSE 0.00 % 0.00 %

N/A

N/A
TASE:LSE 0.00 % 0.00 %

N/A

N/A
QDVM:F 0.00 % 0.00 %

N/A

N/A
QDVM:XETRA 0.00 % 0.00 %

N/A

N/A
FLWG:LSE 0.00 % 0.00 %

N/A

N/A
FLWR:LSE 0.00 % 0.00 %

N/A

N/A
BLUM:XETRA 0.00 % 0.00 %

N/A

N/A
BLUM:F 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.49% 21% F 14% F
Dividend Return 1.72% 60% D- 39% F
Total Return -10.78% 21% F 14% F
Trailing 12 Months  
Capital Gain -15.61% 20% F 12% F
Dividend Return 2.47% 80% B- 38% F
Total Return -13.14% 20% F 12% F
Trailing 5 Years  
Capital Gain -49.02% 36% F 10% F
Dividend Return 8.61% 50% F 29% F
Total Return -40.42% 43% F 10% F
Average Annual (5 Year Horizon)  
Capital Gain -13.00% 25% F 6% D-
Dividend Return -10.63% 25% F 6% D-
Total Return 2.36% 67% D+ 50% F
Risk Return Profile  
Volatility (Standard Deviation) 8.10% 100% F 82% B
Risk Adjusted Return -131.20% 6% D- N/A F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector